Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma

Endometrial cancer (EC) is the most common gynecologic malignancy and still remains clinically challenging. We aimed to explore the potential biomarkers of EC and provide a theoretical basis for early screening and targeted therapy. The available transcriptome data from The Cancer Genome Atlas (TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Lulu, Luo, Ji, Wu, Haifang, Chen, Ling, Tang, Xiaoli, Fu, Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054569/
https://www.ncbi.nlm.nih.gov/pubmed/33782625
http://dx.doi.org/10.4081/ejh.2021.3226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054569/
https://www.ncbi.nlm.nih.gov/pubmed/33782625
http://dx.doi.org/10.4081/ejh.2021.3226

Ejemplares similares